Antineutrophil cytoplasmic antibody-negative granulomatosis with polyangiitis localized to the lungs.
Antineutrophil cytoplasmic antibody
Granuloma of unknown cause
Localized granulomatosis with polyangiitis
Non-life-threatening disease
Journal
Respiratory medicine case reports
ISSN: 2213-0071
Titre abrégé: Respir Med Case Rep
Pays: England
ID NLM: 101604463
Informations de publication
Date de publication:
2022
2022
Historique:
received:
30
03
2021
revised:
30
12
2021
accepted:
31
01
2022
entrez:
16
2
2022
pubmed:
17
2
2022
medline:
17
2
2022
Statut:
epublish
Résumé
Patients with granulomatosis with polyangiitis (GPA), formerly known as Wegener's granulomatosis, sometimes exhibit no clinical features. Here, we describe a case of antineutrophil cytoplasmic antibody (ANCA)-negative GPA presenting with only lung granuloma. A 55-year-old woman with a right upper lung mass underwent lobectomy for suspected lung cancer; however, only granuloma was detected, and the etiology was not identified. Serum ANCA results were negative. Four years postoperatively, another pulmonary nodule appeared in the left lung's apex. The kidneys and sinuses were not impaired, but re-examination of the resected specimen revealed necrotizing vasculitis and granulomas around the vessels. Thus, the patient was diagnosed with GPA localized to the lungs. Although this was a non-life-threatening disease, the patient was administered oral prednisolone (PSL) and intravenous cyclophosphamide (IVCY) to prevent fatal complications of GPA as she was non-elderly and had no comorbidities, leading to a decrease in the mass size. Detailed re-examination by expert pulmonary pathologists could aid in GPA diagnosis when clinical features are absent, as in our case. In patients with granulomas of unknown etiology, a careful multidisciplinary approach is pivotal in the diagnosis. If patients tolerate adverse effects, a PSL and IVCY combination may prevent fatal outcomes, even in patients with non-life-threatening disease.
Identifiants
pubmed: 35169540
doi: 10.1016/j.rmcr.2022.101600
pii: S2213-0071(22)00022-3
pmc: PMC8829757
doi:
Types de publication
Case Reports
Langues
eng
Pagination
101600Informations de copyright
© 2022 The Authors. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
None.
Références
Chest. 1993 Sep;104(3):955-6
pubmed: 8365320
Arthritis Rheum. 2005 Aug;52(8):2461-9
pubmed: 16052573
Eur Respir Rev. 2017 Aug 9;26(145):
pubmed: 28794143
Am J Med. 1954 Aug;17(2):168-79
pubmed: 13180525
Hum Pathol. 1988 Sep;19(9):1065-71
pubmed: 3417290
Case Rep Pulmonol. 2019 Nov 21;2019:5242634
pubmed: 31871812
Ann Rheum Dis. 1993 Feb;52(2):115-20
pubmed: 8383482
Ann Rheum Dis. 2010 Nov;69(11):1934-9
pubmed: 20511614
Am J Med. 2007 Jul;120(7):643.e9-14
pubmed: 17602941
Hum Pathol. 1981 May;12(5):458-67
pubmed: 7250958
Arthritis Rheum. 1998 Sep;41(9):1521-37
pubmed: 9751084
Am J Surg Pathol. 1991 Apr;15(4):315-33
pubmed: 2006712
Curr Opin Rheumatol. 2018 Jul;30(4):388-394
pubmed: 29621029
Rev Port Pneumol. 2013 Jan-Feb;19(1):45-8
pubmed: 22748944
Eur J Case Rep Intern Med. 2017 Jun 18;4(8):000625
pubmed: 30755960
BMC Pulm Med. 2019 Jul 8;19(1):122
pubmed: 31286925
Adv Respir Med. 2019;87(6):258-264
pubmed: 31970728
Arch Intern Med. 1989 Nov;149(11):2461-5
pubmed: 2684074
Ann Rheum Dis. 2016 Sep;75(9):1583-94
pubmed: 27338776
J Intern Med. 1990 Mar;227(3):215-7
pubmed: 2313230